• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Vaccinating children in high-endemic rabies regions: what are we waiting for?

作者信息

Soentjens Patrick, Berens-Riha Nicole, Van Herrewege Yven, Van Damme Pierre, Bottieau Emmanuel, Ravinetto Raffaella

机构信息

Department of Clinical Sciences, Institute of Tropical Medicine, Antwerpen, Belgium

Centre for Infectious Diseases, MHKA, Brussel, Belgium.

出版信息

BMJ Glob Health. 2021 Feb;6(2). doi: 10.1136/bmjgh-2020-004074.

DOI:10.1136/bmjgh-2020-004074
PMID:33568394
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7878157/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a18e/7878157/56ab4e99e77b/bmjgh-2020-004074f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a18e/7878157/56ab4e99e77b/bmjgh-2020-004074f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a18e/7878157/56ab4e99e77b/bmjgh-2020-004074f01.jpg

相似文献

1
Vaccinating children in high-endemic rabies regions: what are we waiting for?在狂犬病高流行地区为儿童接种疫苗：我们还在等什么？
BMJ Glob Health. 2021 Feb;6(2). doi: 10.1136/bmjgh-2020-004074.
2
[Situation of endemic rabies in Madagascar].[马达加斯加的地方性狂犬病情况]
Arch Inst Pasteur Madagascar. 1993;60(1-2):5-8.
3
Endemic rabies in Ghana. Epidemiology and control measures.加纳的地方性狂犬病。流行病学与防控措施。
Am J Trop Med Hyg. 1976 Sep;25(5):724-9. doi: 10.4269/ajtmh.1976.25.724.
4
'Alternative abridged preventive regimens against rabies for children in high endemic countries'.
Vaccine. 2020 Jul 31;38(35):5578-5579. doi: 10.1016/j.vaccine.2020.06.029.
5
[Rabies in Poland in 2007].[2007年波兰的狂犬病]
Przegl Epidemiol. 2009;63(2):257-61.
6
A milestone towards eliminating rabies.消除狂犬病的一个里程碑。
Vet Rec. 2018 Jun 30;182(26):732-733. doi: 10.1136/vr.k2841.
7
Fighting rabies in Africa: the Africa Rabies Expert Bureau (AfroREB).在非洲抗击狂犬病：非洲狂犬病专家局（AfroREB）。
Vaccine. 2008 Nov 25;26(50):6295-8. doi: 10.1016/j.vaccine.2008.04.087. Epub 2008 May 28.
8
Retrospective: animal attacks and rabies exposures in Thai children.回顾性研究：泰国儿童遭受动物袭击及狂犬病暴露情况
Travel Med Infect Dis. 2006 Sep;4(5):270-4. doi: 10.1016/j.tmaid.2005.06.001. Epub 2005 Aug 15.
9
[Human rabies in Senegal: epidemiological and clinical aspects].
Dakar Med. 1991;36(2):105-11.
10
Population dynamics of fox rabies in Europe.欧洲狐狸狂犬病的种群动态
Nature. 1981 Feb 26;289(5800):765-71. doi: 10.1038/289765a0.

引用本文的文献

1
Effectiveness of educational interventions for improving rabies prevention in children: A systematic review and meta-analysis.教育干预对改善儿童狂犬病预防的效果：一项系统评价与荟萃分析。
J Educ Health Promot. 2024 Dec 28;13:497. doi: 10.4103/jehp.jehp_238_24. eCollection 2024.
2
Shaping the future of global access to safe, effective, appropriate and quality health products.塑造全球获取安全、有效、适宜和优质健康产品的未来。
BMJ Glob Health. 2024 Jan 9;9(1):e014425. doi: 10.1136/bmjgh-2023-014425.
3
Rabies control in high-burden countries: role of universal pre-exposure immunization.

本文引用的文献

1
High time to prioritize rabies prevention-a new paradigm.是时候优先考虑狂犬病预防了——一种新的模式。
J Travel Med. 2020 Nov 9;27(7). doi: 10.1093/jtm/taaa173.
2
Single-visit, 4-site intradermal (ID) rabies vaccination induces robust immune responses 5 years after 1-week, 4-site ID primary post-exposure prophylaxis in the Philippines.单次、四点皮内（ID）狂犬病疫苗接种可诱导菲律宾人在接受一周、四点 ID 基础暴露后预防治疗 5 年后产生强烈的免疫应答。
Vaccine. 2020 May 6;38(21):3740-3746. doi: 10.1016/j.vaccine.2020.03.043. Epub 2020 Apr 9.
3
Comparative Immunogenicity and Safety Trial of 2 Different Schedules of Single-visit Intradermal Rabies Postexposure Vaccination.
高负担国家的狂犬病防控：全程暴露前免疫的作用
Lancet Reg Health Southeast Asia. 2023 Aug 1;19:100258. doi: 10.1016/j.lansea.2023.100258. eCollection 2023 Dec.
4
A Cost-Effectiveness Analysis of Pre-Exposure Prophylaxis to Avert Rabies Deaths in School-Aged Children in India.印度学龄儿童暴露前预防狂犬病死亡的成本效益分析。
Vaccines (Basel). 2022 Dec 30;11(1):88. doi: 10.3390/vaccines11010088.
5
The potential for the double risk of rabies and antimicrobial resistance in a high rabies endemic setting: detection of antibiotic resistance in bacterial isolates from infected dog bite wounds in Uganda.在高狂犬病流行地区存在狂犬病和抗菌药物耐药性双重风险的可能性：在乌干达因狗咬伤而感染的细菌分离物中检测到抗生素耐药性。
Antimicrob Resist Infect Control. 2022 Nov 13;11(1):142. doi: 10.1186/s13756-022-01181-0.
6
Safety and immunogenicity of a simian-adenovirus-vectored rabies vaccine: an open-label, non-randomised, dose-escalation, first-in-human, single-centre, phase 1 clinical trial.一种基于猴腺病毒载体的狂犬病疫苗的安全性和免疫原性：一项开放性、非随机、剂量递增、首次人体、单中心、I 期临床试验。
Lancet Microbe. 2022 Sep;3(9):e663-e671. doi: 10.1016/S2666-5247(22)00126-4. Epub 2022 Jul 27.
单次皮内狂犬病暴露后接种不同方案的免疫原性和安全性比较试验。
Clin Infect Dis. 2019 Aug 16;69(5):797-804. doi: 10.1093/cid/ciy983.
4
Modelling to inform prophylaxis regimens to prevent human rabies.建立模型以确定预防人类狂犬病的预防方案。
Vaccine. 2019 Oct 3;37 Suppl 1(Suppl 1):A166-A173. doi: 10.1016/j.vaccine.2018.11.010. Epub 2018 Dec 7.
5
Travel vaccine preventable diseases-updated logarithmic scale with monthly incidence rates.可通过旅行疫苗预防的疾病——按每月发病率更新的对数尺度。
J Travel Med. 2018 Jul 1;25(1). doi: 10.1093/jtm/tay046.
6
Preexposure Intradermal Rabies Vaccination: A Noninferiority Trial in Healthy Adults on Shortening the Vaccination Schedule From 28 to 7 Days.皮内狂犬病预防性疫苗接种：一项在健康成年人中缩短 28 天接种方案至 7 天的非劣效性试验。
Clin Infect Dis. 2019 Feb 1;68(4):607-614. doi: 10.1093/cid/ciy513.
7
Protecting children from rabies with education and pre-exposure prophylaxis: A school-based campaign in El Nido, Palawan, Philippines.通过教育和暴露前预防来保护儿童免受狂犬病侵害：菲律宾巴拉望省爱妮岛的一项校园活动。
PLoS One. 2018 Jan 2;13(1):e0189596. doi: 10.1371/journal.pone.0189596. eCollection 2018.
8
Pre-exposure rabies prophylaxis: a systematic review.暴露前狂犬病预防：一项系统评价
Bull World Health Organ. 2017 Mar 1;95(3):210-219C. doi: 10.2471/BLT.16.173039. Epub 2016 Nov 25.
9
Assessment of acceptability and usability of new delivery prototype device for intradermal vaccination in healthy subjects.健康受试者皮内接种新给药原型装置的可接受性和可用性评估。
Hum Vaccin Immunother. 2014;10(12):3746-53. doi: 10.4161/21645515.2014.979655.